{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:22:07Z","timestamp":1788463327420,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81873181"],"award-info":[{"award-number":["81873181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences","award":["CI2021A05404"],"award-info":[{"award-number":["CI2021A05404"]}]},{"name":"Central public welfare research institutes","award":["Z0852"],"award-info":[{"award-number":["Z0852"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"DOI":"10.1007\/s11306-026-02475-9","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:29:51Z","timestamp":1783780191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A metabolomic signatures in hyperuricemia: a systematic review"],"prefix":"10.1007","volume":"22","author":[{"given":"Yingnan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"2475_CR1","doi-asserted-by":"publisher","first-page":"7520632","DOI":"10.1155\/2022\/7520632","volume":"2022","author":"A Akbari","year":"2022","unstructured":"Akbari, A., Rafiee, M., Sathyapalan, T., & Sahebkar, A. (2022). Impacts of Sodium\/Glucose Cotransporter-2 Inhibitors on Circulating Uric Acid Concentrations: A Systematic Review and Meta-Analysis. Journal of Diabetes Research, 2022, 7520632.","journal-title":"Journal of Diabetes Research"},{"key":"2475_CR2","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1093\/jn\/nxab144","volume":"151","author":"S Ayoub-Charette","year":"2021","unstructured":"Ayoub-Charette, S., Chiavaroli, L., Liu, Q., Khan, T. A., Zurbau, A., Au-Yeung, F., Cheung, A., Ahmed, A., Lee, D., Choo, V. L., Blanco Mejia, S., de Souza, R. J., Wolever, T. M., Leiter, L. A., Kendall, C. W., Jenkins, D. J., & Sievenpiper, J. L. (2021). Different food sources of fructose-containing sugars and fasting blood uric acid levels: A systematic review and meta-analysis of controlled feeding trials. The Journal of Nutrition, 151, 2409\u20132421.","journal-title":"The Journal of Nutrition"},{"key":"2475_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40620-020-00702-7","volume":"33","author":"B Bonino","year":"2020","unstructured":"Bonino, B., Leoncini, G., Russo, E., Pontremoli, R., & Viazzi, F. (2020). Uric acid in CKD: Has the jury come to the verdict? Journal of Nephrology, 33, 715\u2013724.","journal-title":"Journal of Nephrology"},{"key":"2475_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019088","volume":"99","author":"S Chen","year":"2020","unstructured":"Chen, S., Yang, H., Chen, Y., Wang, J., Xu, L., Miao, M., & Xu, C. (2020). Association between serum uric acid levels and dyslipidemia in Chinese adults: A cross-sectional study and further meta-analysis. Medicine (Baltimore), 99, Article e19088.","journal-title":"Medicine (Baltimore)"},{"key":"2475_CR5","doi-asserted-by":"publisher","first-page":"9416","DOI":"10.1039\/D1FO01830B","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen, J., Xu, L., Jiang, L., Wu, Y., Wei, L., Wu, X., Xiao, S., Liu, Y., Gao, C., Cai, J., & Su, Z. (2021). Sonneratia apetala seed oil attenuates potassium oxonate\/hypoxanthine-induced hyperuricemia and renal injury in mice. Food & Function, 12, 9416\u20139431.","journal-title":"Food & Function"},{"key":"2475_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114379","volume":"237","author":"JS Chen","year":"2022","unstructured":"Chen, J. S., Wang, M. X., Wang, M. M., Zhang, Y. K., Guo, X., Chen, Y. Y., Zhang, M. Q., Sun, J. Y., Liu, Y. F., & Liu, C. (2022). Synthesis and biological evaluation of geniposide derivatives as inhibitors of hyperuricemia, inflammatory and fibrosis. European Journal of Medicinal Chemistry, 237, Article 114379.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"2475_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103546","volume":"81","author":"X Chen","year":"2025","unstructured":"Chen, X., Zou, G., Yang, Z., Qi, X., Song, F., Peng, L., Wang, D., Zhou, J., Ma, J., He, H., Hong, Y., Wang, Y. E., Fan, Y., Liu, Z., & Li, X. (2025). Serum metabolomic profiling uncovered metabolic shifts in individuals upon moderate-altitude exposure and identified the potentiality of beta-alanine to ameliorate hyperuricemia. Redox Biology, 81, Article 103546.","journal-title":"Redox Biology"},{"key":"2475_CR8","first-page":"76","volume":"33","author":"J Cheng","year":"2023","unstructured":"Cheng, J., Mei, Y., Chen, Q., & Li, Y. (2023). Correlation between Serum Testosterone and Estimated Glomerular Filtration Rate in Male Patients with Hyperuricemia. Chinese Journal of Microcirculation, 33, 76\u201378.","journal-title":"Chinese Journal of Microcirculation"},{"key":"2475_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/09637486.2024.2400489","volume":"75","author":"X Chi","year":"2024","unstructured":"Chi, X., Cen, Y., Yang, B., Zhang, H., Pu, Z., Feng, J., Pan, H., & Zhang, Y. (2024). Effects of dietary factors on hyperuricaemia and gout: A systematic review and meta-analysis of observational studies. International Journal of Food Sciences and Nutrition, 75, 753\u2013773.","journal-title":"International Journal of Food Sciences and Nutrition"},{"key":"2475_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","volume":"103","author":"S Copur","year":"2022","unstructured":"Copur, S., Demiray, A., & Kanbay, M. (2022). Uric acid in metabolic syndrome: Does uric acid have a definitive role? European Journal of Internal Medicine, 103, 4\u201312.","journal-title":"European Journal of Internal Medicine"},{"key":"2475_CR11","volume-title":"Determination of organic acids and thiols content in seminal plasma of patients with hyperuricemia and its clinical value","author":"T Cui","year":"2020","unstructured":"Cui, T. (2020). Determination of organic acids and thiols content in seminal plasma of patients with hyperuricemia and its clinical value. Hebei Normal University."},{"key":"2475_CR12","doi-asserted-by":"publisher","first-page":"11737","DOI":"10.1021\/acs.analchem.7b03232","volume":"89","author":"L Cui","year":"2017","unstructured":"Cui, L., Liu, J., Yan, X., & Hu, S. (2017). Identification of Metabolite Biomarkers for Gout Using Capillary Ion Chromatography with Mass Spectrometry. Analytical Chemistry, 89, 11737\u201311743.","journal-title":"Analytical Chemistry"},{"key":"2475_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024). Hyperuricemia and its related diseases: Mechanisms and advances in therapy. Signal Transduct Target Ther, 9, 212.","journal-title":"Signal Transduct Target Ther"},{"key":"2475_CR14","first-page":"245","volume":"27","author":"FT Fang Jiawen","year":"2024","unstructured":"Fang Jiawen, F. T., Zhiheng, Z., Ziyue, L., & Danhong, Y., Lin Kaicheng (2024). Trends in the Burden of Gout in China from 1990 to 2019 and Projections for the Next Decade. Chinese General Practice, 27, 245\u2013252.","journal-title":"Chinese General Practice"},{"key":"2475_CR15","first-page":"461","volume":"43","author":"LL Fang Ningyuan","year":"2023","unstructured":"Fang Ningyuan, L. L., L\u00fc Xiaoxi, X., Yang, L., Bing, L., Caifeng, H., Chao, C., Wei, C., Tong, Z., Jianjun, G., Xin, F., Song, W., & Li, D. (2023). Jianghong Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia-Related Diseases in China (2023 Edition). Chinese Journal of Practical Internal Medicine, 43, 461\u2013480.","journal-title":"Chinese Journal of Practical Internal Medicine"},{"key":"2475_CR16","volume":"12","author":"L Gao","year":"2025","unstructured":"Gao, L., Zhang, Y., Hu, Z., Chen, S., Wang, Q., Zeng, Y., Yin, H., Zhao, J., Zhan, Y., Gao, C., Xin, Y., Chen, B., van der Veen, S., Zhao, M., Fang, D., & Lu, Q. (2025). Microbiota-derived inosine suppresses systemic autoimmunity via restriction of B cell differentiation and migration. Advanced Science (Weinheim, Germany), 12, Article e2409837.","journal-title":"Advanced Science (Weinheim, Germany)"},{"key":"2475_CR17","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s11255-022-03125-4","volume":"54","author":"YH Geng","year":"2022","unstructured":"Geng, Y. H., Zhang, Z., Zhang, J. J., Huang, B., Guo, Z. S., Wang, X. T., Zhang, L. Q., Quan, S. X., Hu, R. M., & Liu, Y. F. (2022). Hyperuricemia aggravates the progression of IgA nephropathy. International Urology and Nephrology, 54, 2227\u20132237.","journal-title":"International Urology and Nephrology"},{"key":"2475_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nbt.4101","volume":"36","author":"C Guijas","year":"2018","unstructured":"Guijas, C., Montenegro-Burke, J. R., Warth, B., Spilker, M. E., & Siuzdak, G. (2018). Metabolomics activity screening for identifying metabolites that modulate phenotype. Nature Biotechnology, 36, 316\u2013320.","journal-title":"Nature Biotechnology"},{"key":"2475_CR19","first-page":"536","volume":"16","author":"J Han","year":"2018","unstructured":"Han, J., An, B., Ji, Z., & Ji, W. (2018). NMR-Based Metabolomic Profiling of Essential Hypertension Complicated with Hyperuricemia. Chinese Journal of Integrative Medicine on Cardio-\/Cerebrovascular Disease, 16, 536\u2013542.","journal-title":"Chinese Journal of Integrative Medicine on Cardio-\/Cerebrovascular Disease"},{"key":"2475_CR20","doi-asserted-by":"publisher","first-page":"147366","DOI":"10.1016\/j.ijbiomac.2025.147366","volume":"327","author":"R Han","year":"2025","unstructured":"Han, R., Li, Y., Fu, T., Yu, Y., Shan, M., Hao, J., Chen, H., Mao, T., Qi, X., Cao, B., Wang, Y., Liu, X., & Tian, Z. (2025). Fucoidan-driven Bacteroides xylanisolvens HS-1 alleviates hyperuricemia by promoting intestinal uric acid excretion via the PPARgamma\/ABCG2 signaling pathway. International Journal of Biological Macromolecules, 327, 147366.","journal-title":"International Journal of Biological Macromolecules"},{"key":"2475_CR21","first-page":"419","volume":"18","author":"P Hongcheng","year":"2023","unstructured":"Hongcheng, P., L.J (2023). Research Progress on the Treatment of Hyperuricemia with Traditional Chinese Medicine. World Journal of Integrated Traditional and Western Medicine, 18, 419\u2013424.","journal-title":"World Journal of Integrated Traditional and Western Medicine"},{"key":"2475_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","volume":"16","author":"H Huang","year":"2014","unstructured":"Huang, H., Huang, B., Li, Y., Huang, Y., Li, J., Yao, H., Jing, X., Chen, J., & Wang, J. (2014). Uric acid and risk of heart failure: A systematic review and meta-analysis. European Journal of Heart Failure, 16, 15\u201324.","journal-title":"European Journal of Heart Failure"},{"key":"2475_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s41256-020-00178-9","volume":"5","author":"J Huang","year":"2020","unstructured":"Huang, J., Ma, Z. F., Zhang, Y., Wan, Z., Li, Y., Zhou, H., Chu, A., & Lee, Y. Y. (2020). Geographical distribution of hyperuricemia in mainland China: A comprehensive systematic review and meta-analysis. Glob Health Res Policy, 5, 52.","journal-title":"Glob Health Res Policy"},{"key":"2475_CR24","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1872-2040(16)60950-7","volume":"44","author":"R Jia","year":"2016","unstructured":"Jia, R., Zhang, Q., Liu, J., Hojeij, M., & Girault, H., H (2016). Kinetic Model for the Quenching of Photo-induced Reactive Oxygen Species by Biological Antioxidants. Chinese Journal of Analytical Chemistry, 44, 1257\u20131262.","journal-title":"Chinese Journal of Analytical Chemistry"},{"key":"2475_CR25","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.3390\/cells10112832","volume":"10","author":"Q Jin","year":"2021","unstructured":"Jin, Q., & Ma, R. C. W. (2021). Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies. Cells, 10, 2832.","journal-title":"Cells"},{"key":"2475_CR26","first-page":"659","volume":"66","author":"Y Kanai","year":"2008","unstructured":"Kanai, Y. (2008). [Molecular mechanisms of urate transport in renal tubules: Localization and function of urate transporters]. Nihon Rinsho, 66, 659\u2013666.","journal-title":"Nihon Rinsho"},{"key":"2475_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028998","volume":"101","author":"SW Lai","year":"2022","unstructured":"Lai, S. W., Hwang, B. F., Kuo, Y. H., Liu, C. S., & Liao, K. F. (2022). A meta-analysis of allopurinol therapy and the risk of prostate cancer. Medicine (Baltimore), 101, Article e28998.","journal-title":"Medicine (Baltimore)"},{"key":"2475_CR28","doi-asserted-by":"publisher","first-page":"e13156","DOI":"10.1111\/eci.13156","volume":"49","author":"YH Lee","year":"2019","unstructured":"Lee, Y. H., & Song, G. G. (2019). Uric acid level, gout and bone mineral density: A Mendelian randomization study. European Journal of Clinical Investigation, 49, e13156.","journal-title":"European Journal of Clinical Investigation"},{"key":"2475_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00393-024-01600-0","volume":"83","author":"YH Lee","year":"2024","unstructured":"Lee, Y. H., & Song, G. G. (2024). Effect of urate-lowering therapy on all-cause and CVD-specific mortality in gout and hyperuricemia: A meta-analysis. Zeitschrift Fur Rheumatologie, 83, 338\u2013344.","journal-title":"Zeitschrift Fur Rheumatologie"},{"key":"2475_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026677","volume":"9","author":"Q Li","year":"2019","unstructured":"Li, Q., Li, X., Wang, J., Liu, H., Kwong, J. S., Chen, H., Li, L., Chung, S. C., Shah, A., Chen, Y., An, Z., Sun, X., Hemingway, H., Tian, H., & Li, S. (2019). Diagnosis and treatment for hyperuricemia and gout: A systematic review of clinical practice guidelines and consensus statements. BMJ Open, 9, Article e026677.","journal-title":"BMJ Open"},{"key":"2475_CR31","doi-asserted-by":"publisher","first-page":"loae018","DOI":"10.1093\/lifemeta\/loae018","volume":"3","author":"N Liang","year":"2024","unstructured":"Liang, N., Yuan, X., Zhang, L., Shen, X., Zhong, S., Li, L., Li, R., Xu, X., Chen, X., Yin, C., Guo, S., Ge, J., Zhu, M., Tao, Y., Chen, S., Qian, Y., Dalbeth, N., Merriman, T. R., Terkeltaub, R., \u2026 Yin, H. (2024). Fatty acid oxidation-induced HIF-1\u03b1 activation facilitates hepatic urate synthesis through upregulating NT5C2 and XDH. Life Metabolism, 3, loae018.","journal-title":"Life Metabolism"},{"key":"2475_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11306-025-02261-z","volume":"21","author":"YL Lin","year":"2025","unstructured":"Lin, Y. L., & Yang, Y. C. (2025). Volatile organic compound exposure is associated with hyperuricemia in the general population: an analysis of 6878 adults from the NHANES. Metabolomics, 21, 60.","journal-title":"Metabolomics"},{"key":"2475_CR33","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1093\/rheumatology\/keab743","volume":"61","author":"S Liu","year":"2022","unstructured":"Liu, S., Wang, Y., Liu, H., Xu, T., Wang, M. J., Lu, J., Guo, Y., Chen, W., Ke, M., Zhou, G., Lu, Y., Chen, P., & Zhou, W. (2022). Serum lipidomics reveals distinct metabolic profiles for asymptomatic hyperuricemic and gout patients. Rheumatology, 61, 2644\u20132651.","journal-title":"Rheumatology"},{"key":"2475_CR34","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1038\/s41598-023-34426-y","volume":"13","author":"H Liu","year":"2023","unstructured":"Liu, H., Xie, R., Dai, Q., Fang, J., Xu, Y., & Li, B. (2023a). Exploring the mechanism underlying hyperuricemia using comprehensive research on multi-omics. Scientific Reports, 13, 7161.","journal-title":"Scientific Reports"},{"key":"2475_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.336","volume":"4","author":"N Liu","year":"2023","unstructured":"Liu, N., Huang, L., Xu, H., He, X., He, X., Cao, J., Xu, W., Wang, Y., Wei, H., Wang, S., Zheng, H., Gao, S., Xu, Y., & Lu, W. (2023b). Phosphatidylserine decarboxylase downregulation in uric acid\u2013induced hepatic mitochondrial dysfunction and apoptosis. MedComm, 4, Article e336.","journal-title":"MedComm"},{"key":"2475_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-023-04240-3","author":"S Liu","year":"2023","unstructured":"Liu, S., Liu, Y., Wu, X., & Liu, Z. (2023c). Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology. Journal of Orthopaedic Surgery and Research. https:\/\/doi.org\/10.1186\/s13018-023-04240-3","journal-title":"Journal of Orthopaedic Surgery and Research"},{"key":"2475_CR37","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo, D., Wan, X., Liu, J., & Tong, T. (2018a). Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Statistical Methods In Medical Research, 27, 1785\u20131805.","journal-title":"Statistical Methods In Medical Research"},{"key":"2475_CR38","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00726-018-2627-2","volume":"50","author":"Y Luo","year":"2018","unstructured":"Luo, Y., Wang, L., Liu, X. Y., Chen, X., Song, Y. X., Li, X. H., Jiang, C., Peng, A., & Liu, J. Y. (2018b). Plasma profiling of amino acids distinguishes acute gout from asymptomatic hyperuricemia. Amino Acids, 50, 1539\u20131548.","journal-title":"Amino Acids"},{"key":"2475_CR39","unstructured":"Lv, W. (2022). High-coverage metabolomics analytical method developmentbased on dual liquid chromatography-mass spectrometry, University of Chinese Academy of Science, University of Chinese Academy of Science."},{"key":"2475_CR40","unstructured":"Ma, L. (2013). Study on Multiple \u2013viamins Intervention of Asymptomatic Hyperuricemia in Xinjiang Uyghur and Han Etinicity. XinJinag Medical Uniersity."},{"key":"2475_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-45564-8","author":"L Ma","year":"2023","unstructured":"Ma, L., Wang, J., Ma, L., Ge, Y., & Wang, X. M. (2023a). The effect of lipid metabolism disorder on patients with hyperuricemia using multi-omics analysis. Scientific Reports. https:\/\/doi.org\/10.1038\/s41598-023-45564-8","journal-title":"Scientific Reports"},{"key":"2475_CR42","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1039\/D2FO02860C","volume":"14","author":"N Ma","year":"2023","unstructured":"Ma, N., Zhang, Y., Wang, T., Sun, Y., & Cai, S. (2023b). The preventive effect of Chinese sumac fruit against monosodium urate-induced gouty arthritis in rats by regulating several inflammatory pathways. Food & Function, 14, 1148\u20131159.","journal-title":"Food & Function"},{"key":"2475_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149043","author":"A Motta","year":"2016","unstructured":"Motta, A., Tan, Y., Liu, X., Zhou, K., He, X., Lu, C., He, B., Niu, X., Xiao, C., Xu, G., Bian, Z., Zu, X., Zhang, G., Zhang, W., & Lu, A. (2016). The potential biomarkers to identify the development of steatosis in hyperuricemia. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0149043","journal-title":"PLoS ONE"},{"key":"2475_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.rdc.2006.02.006","volume":"32","author":"DB Mount","year":"2006","unstructured":"Mount, D. B., Kwon, C. Y., & Zandi-Nejad, K. (2006). Renal urate transport. Rheum Dis Clin North Am, 32, 313\u2009\u2013\u2009331.","journal-title":"Rheum Dis Clin North Am"},{"key":"2475_CR45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.ajkd.2022.05.010","volume":"81","author":"Y Ohashi","year":"2023","unstructured":"Ohashi, Y., Kuriyama, S., Nakano, T., Sekine, M., Toyoda, Y., Nakayama, A., Takada, T., Kawamura, Y., Nakamura, T., Matsuo, H., Yokoo, T., & Ichida, K. (2023). Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression. American Journal of Kidney Diseases, 81, 134-144e1.","journal-title":"American Journal of Kidney Diseases"},{"key":"2475_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1742-4682-4-9","volume":"4","author":"A Olgun","year":"2007","unstructured":"Olgun, A. (2007). Biological effects of deuteronation: ATP synthase as an example. Theoretical Biology & Medical Modelling, 4, 9.","journal-title":"Theoretical Biology & Medical Modelling"},{"key":"2475_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hr\u00f3bjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., \u2026 Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Bmj, 372, Article n71.","journal-title":"Bmj"},{"key":"2475_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tcb.2023.04.007","volume":"34","author":"A Pfeifer","year":"2024","unstructured":"Pfeifer, A., Mikhael, M., & Niemann, B. (2024). Inosine: Novel activator of brown adipose tissue and energy homeostasis. Trends In Cell Biology, 34, 72\u201382.","journal-title":"Trends In Cell Biology"},{"key":"2475_CR49","doi-asserted-by":"crossref","unstructured":"Qin, N. (2021). Research on Biomarkers of Hyperuricemia Based on Untargeted and Targeted Metabolomics. Beijing University of Chinese Medicien.","DOI":"10.1038\/s41598-022-18361-y"},{"key":"2475_CR50","first-page":"80","volume":"14","author":"F Roch-Ramel","year":"1999","unstructured":"Roch-Ramel, F., & Guisan, B. (1999). Renal Transport of Urate in Humans. News In Physiological Sciences, 14, 80\u201384.","journal-title":"News In Physiological Sciences"},{"key":"2475_CR51","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1373\/clinchem.2005.050211","volume":"51","author":"GM Rodgers","year":"2005","unstructured":"Rodgers, G. M., Roberts, W. L., Crist, R. A., & Flanders, M. M. (2005). Pediatric Reference Intervals for Seven Common Coagulation Assays. Clinical Chemistry, 51, 1738\u20131742.","journal-title":"Clinical Chemistry"},{"key":"2475_CR52","first-page":"Cd009460","volume":"10","author":"AL Sampson","year":"2017","unstructured":"Sampson, A. L., Singer, R. F., & Walters, G. D. (2017). Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease. Cochrane Database Systematic Review, 10, Cd009460.","journal-title":"Cochrane Database Systematic Review"},{"key":"2475_CR53","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/art.41733","volume":"73","author":"X Shen","year":"2021","unstructured":"Shen, X., Wang, C., Liang, N., Liu, Z., Li, X., Zhu, Z. J., Merriman, T. R., Dalbeth, N., Terkeltaub, R., Li, C., & Yin, H. (2021). Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout. Arthritis & Rheumatology, 73, 1738\u20131748.","journal-title":"Arthritis & Rheumatology"},{"key":"2475_CR54","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal Of Epidemiology, 25, 603\u2013605.","journal-title":"European Journal Of Epidemiology"},{"key":"2475_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1743-7075-7-16","volume":"7","author":"SZ Sun","year":"2010","unstructured":"Sun, S. Z., Flickinger, B. D., Williamson-Hughes, P. S., & Empie, M. W. (2010). Lack of association between dietary fructose and hyperuricemia risk in adults. Nutrition & Metabolism (Lond), 7, 16.","journal-title":"Nutrition & Metabolism (Lond)"},{"key":"2475_CR110","doi-asserted-by":"publisher","unstructured":"Tan, Y., Liu, X., Zhou, K., He, X., Lu, C., He, B., Niu, X., Xiao, C., Xu, G., Bian, Z., Zu, X., Zhang, G., Zhang, W., & Lu, A. (2016). The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia. PloS One, 11(2), e0149043. https:\/\/doi.org\/10.1371\/journal.pone.0149043","DOI":"10.1371\/journal.pone.0149043"},{"key":"2475_CR56","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3122\/jabfm.2022.01.210273","volume":"35","author":"YY Tien","year":"2022","unstructured":"Tien, Y. Y., Shih, M. C., Tien, C. P., Huang, H. K., & Tu, Y. K. (2022). To Treat or Not to Treat? Effect of Urate-Lowering Therapy on Renal Function, Blood Pressure and Safety in Patients with Asymptomatic Hyperuricemia: A Systematic Review and Network Meta-Analysis. Journal of The American Board of Family Medicine\u202f: Jabfm, 35, 140\u2013151.","journal-title":"Journal of The American Board of Family Medicine : Jabfm"},{"key":"2475_CR57","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3904\/kjim.2020.340","volume":"36","author":"Y Waheed","year":"2021","unstructured":"Waheed, Y., Yang, F., & Sun, D. (2021). Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease. Korean Journal of Internal Medicine, 36, 1281\u20131293.","journal-title":"Korean Journal of Internal Medicine"},{"key":"2475_CR58","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/acr.24013","volume":"72","author":"F Wang","year":"2020","unstructured":"Wang, F., Sun, L., Zong, G., Gao, X., Zhang, H., Xiong, Q., Huo, S., Niu, Z., Sun, Q., Zeng, R., & Lin, X. (2020). Associations of Amino Acid and Acylcarnitine Profiles With Incident Hyperuricemia in Middle-Aged and Older Chinese Individuals. Arthritis Care & Research (Hoboken), 72, 1305\u20131314.","journal-title":"Arthritis Care & Research (Hoboken)"},{"key":"2475_CR59","doi-asserted-by":"publisher","first-page":"773001","DOI":"10.3389\/fimmu.2022.773001","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang, H., Xie, L., Song, X., Wang, J., Li, X., Lin, Z., Su, T., Liang, B., & Huang, D. (2022). Purine-Induced IFN-gamma Promotes Uric Acid Production by Upregulating Xanthine Oxidoreductase Expression. Frontiers In Immunology, 13, 773001.","journal-title":"Frontiers In Immunology"},{"key":"2475_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-023-03585-z","author":"W Wang","year":"2023","unstructured":"Wang, W., Kou, J., Zhang, M., Wang, T., Li, W., Wang, Y., Xie, Q., & Wei, M. (2023). A metabonomic study to explore potential markers of asymptomatic hyperuricemia and acute gouty arthritis. Journal of Orthopaedic Surgery and Research. https:\/\/doi.org\/10.1186\/s13018-023-03585-z","journal-title":"Journal of Orthopaedic Surgery and Research"},{"key":"2475_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2025.100422","volume":"9","author":"Y Wang","year":"2025","unstructured":"Wang, Y., Zhang, H., Liu, S., Sun, S., Ren, W., Wang, T., Zhang, S., Yao, H., Jin, C., & Wu, N. (2025). Comparative analysis of hyperuricemia induction methods and probiotic interventions in mice. Current Research in Microbial Sciences, 9, Article 100422.","journal-title":"Current Research in Microbial Sciences"},{"key":"2475_CR62","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s10067-024-06933-4","volume":"43","author":"F Wu","year":"2024","unstructured":"Wu, F., Chen, L., & Du, Y. (2024). Comparison of the efficacy and safety of benzbromarone and febuxostat in gout and hyperuricemia: A systematic review and meta-analysis. Clinical Rheumatology, 43, 1745\u20131754.","journal-title":"Clinical Rheumatology"},{"key":"2475_CR63","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1021\/acs.jproteome.5c00111","volume":"24","author":"P Wu","year":"2025","unstructured":"Wu, P., Pu, L., Zhang, L., Wang, Z., Li, R., Ai, C., Wang, X., Wang, X., Yang, S., Chen, Z., & Liu, W. (2025). Integration of Metabolomics and Proteomics Reveals the Molecular Characterization of High-Altitude Hyperuricemia. Journal of Proteome Research, 24, 3460\u20133469.","journal-title":"Journal of Proteome Research"},{"key":"2475_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179221","author":"H Yanai","year":"2021","unstructured":"Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2021). Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms22179221","journal-title":"International Journal of Molecular Sciences"},{"key":"2475_CR65","volume-title":"Metabonomics characteristics of Hyperuricemia and Common TCM constitution type in middle-aged and old people","author":"Q Yang","year":"2013","unstructured":"Yang, Q. (2013). Metabonomics characteristics of Hyperuricemia and Common TCM constitution type in middle-aged and old people. Guangzhou University of Chinese Medicine."},{"key":"2475_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.106919","volume":"158","author":"L You","year":"2022","unstructured":"You, L., Zheng, F., Su, C., Wang, L., Li, X., Chen, Q., Kou, J., Wang, X., Wang, Y., Wang, Y., Mei, S., Zhang, B., Liu, X., & Xu, G. (2022). Metabolome-wide association study of serum exogenous chemical residues in a cohort with 5 major chronic diseases. Environment International, 158, Article 106919.","journal-title":"Environment International"},{"key":"2475_CR67","first-page":"30","volume":"16","author":"X Yu","year":"2016","unstructured":"Yu, X., Chen, K., & Ying, T. (2016). Lipid metabolism study of hyperuricemia and gout arthritis based on lipidomics technology. World Latest Medicne Information (Electronic Version), 16, 30\u201331.","journal-title":"World Latest Medicne Information (Electronic Version)"},{"key":"2475_CR68","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1161\/HYPERTENSIONAHA.122.18981","volume":"79","author":"H Yun","year":"2022","unstructured":"Yun, H., Sun, L., Wu, Q., Luo, Y., Qi, Q., Li, H., Gu, W., Wang, J., Ning, G., Zeng, R., Zong, G., & Lin, X. (2022). Lipidomic Signatures of Dairy Consumption and Associated Changes in Blood Pressure and Other Cardiovascular Risk Factors Among Chinese Adults. Hypertension, 79, 1617\u20131628.","journal-title":"Hypertension"},{"key":"2475_CR69","unstructured":"Zhang, M. (2013). Effects of Dietary Factors on Hyperuricemiaand Metabolic Syndrome. Tianjin Medical University."},{"key":"2475_CR70","volume-title":"Serum metabonomic of patients with gout and hyperuricemia based on UPLC-MC","author":"M Zhang","year":"2021","unstructured":"Zhang, M. (2021a). Serum metabonomic of patients with gout and hyperuricemia based on UPLC-MC. Southwest Jiaotong University."},{"key":"2475_CR71","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/biom11020280","volume":"11","author":"WZ Zhang","year":"2021","unstructured":"Zhang, W. Z. (2021b). Why Does Hyperuricemia Not Necessarily Induce Gout? Biomolecules, 11, 280.","journal-title":"Biomolecules"},{"key":"2475_CR72","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13075-018-1600-5","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Zhang, H., Chang, D., Guo, F., Pan, H., & Yang, Y. (2018). Metabolomics approach by 1H NMR spectroscopy of serum reveals progression axes for asymptomatic hyperuricemia and gout. Arthritis Research & Therapy, 20, 111.","journal-title":"Arthritis Research & Therapy"},{"key":"2475_CR73","doi-asserted-by":"publisher","first-page":"700","DOI":"10.2174\/1381612825666190408122557","volume":"25","author":"S Zhang","year":"2019","unstructured":"Zhang, S., Wang, Y., Cheng, J., Huangfu, N., Zhao, R., Xu, Z., Zhang, F., Zheng, W., & Zhang, D. (2019). Hyperuricemia and Cardiovascular Disease. Current Pharmaceutical Design, 25, 700\u2013709.","journal-title":"Current Pharmaceutical Design"},{"key":"2475_CR74","doi-asserted-by":"publisher","first-page":"12772","DOI":"10.1038\/s41598-023-40027-6","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang, H., Ma, X., Xu, J., Jin, P., Yang, L., Pan, Y., Yin, F., Zhang, J., Wang, J., Yu, D., Wang, X., Zhang, M., Wang, X., Wang, D., & Sheng, J. (2023). Serum metabolomics of hyperbilirubinemia and hyperuricemia in the Tibetan plateau has unique characteristics. Scientific Reports, 13, 12772.","journal-title":"Scientific Reports"},{"key":"2475_CR75","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1021\/acs.jproteome.3c00760","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Zhao, H., Zhao, J., Lv, W., Jia, X., Lu, X., Zhao, X., & Xu, G. (2024). Quantified Metabolomics and Lipidomics Profiles Reveal Serum Metabolic Alterations and Distinguished Metabolites of Seven Chronic Metabolic Diseases. Journal of Proteome Research, 23, 3076\u20133087.","journal-title":"Journal of Proteome Research"},{"key":"2475_CR100","doi-asserted-by":"publisher","unstructured":"Zhao, J., Liang, Q., Luo, G., Wang, Y., Zuo, Y., Jiang, M., Yu, G., Zhang, T. (2005). Purine metabolites in gout and asymptomatic hyperuricemia: Analysis by HPLC-electrospray tandem mass spectrometry. Clinical Chemistry, 51(9), 1742\u20131744. https:\/\/doi.org\/10.1373\/clinchem.2004.040261","DOI":"10.1373\/clinchem.2004.040261"},{"key":"2475_CR76","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.2147\/DDDT.S524747","volume":"19","author":"L Zhao","year":"2025","unstructured":"Zhao, L., Zhang, Y., Qiao, Y., Jia, L., & Luo, S. (2025). 17(R)-RvD1 Ameliorates Liver Injury in Hyperuricemia Through Inhibiting Pyroptosis via NF-kappaB Signaling Pathway. Drug Design, Development and Therapy, 19, 6573\u20136585.","journal-title":"Drug Design, Development and Therapy"},{"key":"2475_CR77","first-page":"695","volume":"39","author":"Q Zhong","year":"2011","unstructured":"Zhong, Q., Gao, Y., Chang, H., Wang, X., Zhang, M., Bian, S., & Huang, G. (2011). Plasma Metabonomics Analysis of Male Patients with Hyperuricemia. Tianjin Medical Journal, 39, 695\u2013697.","journal-title":"Tianjin Medical Journal"},{"key":"2475_CR78","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4314\/ahs.v21i1.13","volume":"21","author":"Q Zong","year":"2021","unstructured":"Zong, Q., Ma, G., & Wang, T. (2021). Uric acid lowering improves insulin sensitivity and lowers blood pressure: A meta-analysis of randomized parallel-controlled clinical trials. African Health Sciences, 21, 82\u201395.","journal-title":"African Health Sciences"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02475-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-026-02475-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02475-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:02:13Z","timestamp":1788462133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-026-02475-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":80,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2475"],"URL":"https:\/\/doi.org\/10.1007\/s11306-026-02475-9","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"125"}}